DE60228064D1 - Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln - Google Patents

Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln

Info

Publication number
DE60228064D1
DE60228064D1 DE60228064T DE60228064T DE60228064D1 DE 60228064 D1 DE60228064 D1 DE 60228064D1 DE 60228064 T DE60228064 T DE 60228064T DE 60228064 T DE60228064 T DE 60228064T DE 60228064 D1 DE60228064 D1 DE 60228064D1
Authority
DE
Germany
Prior art keywords
pravastatin
mirrors
lowering ldl
cholesterin
medicament
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60228064T
Other languages
English (en)
Inventor
Rene Belder
Mark E Mcgovern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DE60228064D1 publication Critical patent/DE60228064D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60228064T 2001-02-27 2002-01-28 Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln Expired - Lifetime DE60228064D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/794,449 US20020183383A1 (en) 2001-02-27 2001-02-27 Pharmaceutical compositions
PCT/US2002/002736 WO2002067911A1 (en) 2001-02-27 2002-01-28 Pharmaceutical compositions comprising pravastatin for reducing ldl cholesterol levels

Publications (1)

Publication Number Publication Date
DE60228064D1 true DE60228064D1 (de) 2008-09-18

Family

ID=25162649

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60228064T Expired - Lifetime DE60228064D1 (de) 2001-02-27 2002-01-28 Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln

Country Status (9)

Country Link
US (2) US20020183383A1 (de)
EP (1) EP1377277B1 (de)
AR (1) AR033424A1 (de)
AT (1) ATE403423T1 (de)
DE (1) DE60228064D1 (de)
ES (1) ES2309148T3 (de)
PE (1) PE20020893A1 (de)
UY (1) UY27187A1 (de)
WO (1) WO2002067911A1 (de)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030447A (en) * 1988-03-31 1991-07-09 E. R. Squibb & Sons, Inc. Pharmaceutical compositions having good stability
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5298497A (en) * 1990-05-15 1994-03-29 E. R. Squibb & Sons, Inc. Method for preventing onset of hypertension employing a cholesterol lowering drug
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5622985A (en) * 1990-06-11 1997-04-22 Bristol-Myers Squibb Company Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
US5130333A (en) * 1990-10-19 1992-07-14 E. R. Squibb & Sons, Inc. Method for treating type II diabetes employing a cholesterol lowering drug
GB2253787A (en) * 1991-01-28 1992-09-23 Merck & Co Inc Hypercholesterolemia treating compositions
US6369103B1 (en) * 1994-01-18 2002-04-09 Bristol-Myers Squibb Company Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
KR20020063174A (ko) * 1999-11-03 2002-08-01 하워드 제이 스미스 앤드 어쏘시에이츠 피티와이 엘티디 간의 선택적 치료방법

Also Published As

Publication number Publication date
PE20020893A1 (es) 2002-10-25
UY27187A1 (es) 2002-09-30
US20030125379A1 (en) 2003-07-03
ATE403423T1 (de) 2008-08-15
ES2309148T3 (es) 2008-12-16
EP1377277B1 (de) 2008-08-06
EP1377277A1 (de) 2004-01-07
WO2002067911A1 (en) 2002-09-06
AR033424A1 (es) 2003-12-17
US20020183383A1 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
NO20033556D0 (no) Farmasöytiske preparater
DK1412328T3 (da) Dolastatin-10-derivater
DE60208385D1 (de) Antineoplasische kombinationspräparate
ATE380814T1 (de) Kinaseinhibitoren als arzneimittel
DK1397364T3 (da) Hidtil ukendte pyrrolderivater som farmaceutiske midler
NO20040084L (no) Peptid-baserte forbindelser
DK1401806T3 (da) Benzoylsulfonamider og sulfonylbenzamidiner til anvendelse som antitumormidler
DK1463716T3 (da) Pyrrolidin- og piperidinderivater som NK1-antagonister
NO20033785L (no) Farmasöytisk formulering
DK1395242T3 (da) Flydende farmaceutisk sammensætning
IS7549A (is) Olíuleysanlegar efnablöndur
DE60203537D1 (de) 5ht1-rezeptoragonist enthaltendes arzneimittel
IS6126A (is) Nýjar lyfjasamsetningar fyrir NOS lata
DE60033053D1 (de) Projektionsschirm
IL169163A0 (en) Optically active dihydropyridine derivative and pharmaceutical compositions containing the same
ATE269337T1 (de) Trizyclische delta3-pyridine als arzneimittel
DE60228064D1 (de) Pravastatin umfassende arzneimittel zum senken von ldl- cholesterinspiegeln
AU2002221760A1 (en) Vaccine for treating allergy
EE200300465A (et) Püridoindolooni derivaatidel põhinevad farmatseutilised kompositsioonid
FI20012242A0 (fi) Uudet farmaseuttiset yhdisteet
AU2002364684A1 (en) Amphiphilic compounds for pharmaceutical or cosmetic use
PT102547A (pt) Recinto modular para preparacoes estereis
DE50214718D1 (de) Montagewinkel
ES1049975Y (es) Estanteria plegable
NO20042153L (no) Piperidin-2-on-derivatforbindelser og farmasoytisk sammensetning omfattende samme som aktiv ingrediens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition